You just read:

Daiichi Sankyo's FLT3 Inhibitor Quizartinib Receives Orphan Drug Designation from Japanese MHLW for FLT3-Mutated AML

News provided by

Daiichi Sankyo Company, Limited

11 Sep, 2018, 13:00 BST